Amalgamated Bank Buys 1,556 Shares of Centene Co. (NYSE:CNC)

Amalgamated Bank raised its stake in shares of Centene Co. (NYSE:CNC – Get Rating) by 1.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 148,239 shares of the company’s stock after purchasing an additional 1,556 shares during the period. Amalgamated Bank’s holdings in Centene were worth $12,157,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of CNC. Whittier Trust Co. of Nevada Inc. raised its holdings in Centene by 5,700.0% in the 4th quarter. Whittier Trust Co. of Nevada Inc. now owns 348 shares of the company’s stock worth $29,000 after acquiring an additional 342 shares during the period. Guardian Wealth Advisors LLC acquired a new position in shares of Centene during the 3rd quarter worth about $71,000. Covestor Ltd boosted its stake in Centene by 24.1% during the 1st quarter. Covestor Ltd now owns 856 shares of the company’s stock valued at $72,000 after purchasing an additional 166 shares during the period. EverSource Wealth Advisors LLC grew its holdings in Centene by 76.4% in the 4th quarter. EverSource Wealth Advisors LLC now owns 947 shares of the company’s stock valued at $78,000 after buying an additional 410 shares during the last quarter. Finally, U.S. Capital Wealth Advisors LLC acquired a new position in shares of Centene during the fourth quarter worth approximately $86,000. Institutional investors own 93.28% of the company’s stock.

Insider Activity at Centene

In other Centene news, Director Lori Jean Robinson sold 1,400 shares of the stock in a transaction on Thursday, April 27th. The stock was sold at an average price of $66.59, for a total value of $93,226.00. Following the transaction, the director now directly owns 8,508 shares in the company, valued at approximately $566,547.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other Centene news, CEO Sarah London bought 30,000 shares of the stock in a transaction on Friday, March 17th. The stock was purchased at an average price of $62.60 per share, with a total value of $1,878,000.00. Following the acquisition, the chief executive officer now owns 313,953 shares of the company’s stock, valued at $19,653,457.80. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Lori Jean Robinson sold 1,400 shares of the stock in a transaction on Thursday, April 27th. The shares were sold at an average price of $66.59, for a total value of $93,226.00. Following the completion of the transaction, the director now directly owns 8,508 shares in the company, valued at approximately $566,547.72. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by company insiders.

Centene Price Performance

CNC traded down $0.39 during trading on Friday, hitting $63.04. The company’s stock had a trading volume of 936,582 shares, compared to its average volume of 3,655,801. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.72. The stock has a market capitalization of $34.59 billion, a price-to-earnings ratio of 24.03, a price-to-earnings-growth ratio of 0.87 and a beta of 0.56. The firm’s 50 day moving average price is $66.22 and its two-hundred day moving average price is $73.43. Centene Co. has a 12 month low of $61.71 and a 12 month high of $98.53.

Centene (NYSE:CNC – Get Rating) last issued its quarterly earnings data on Tuesday, April 25th. The company reported $2.11 EPS for the quarter, missing analysts’ consensus estimates of $2.23 by ($0.12). Centene had a return on equity of 13.61% and a net margin of 1.01%. The company had revenue of $38.89 billion for the quarter, compared to the consensus estimate of $36.09 billion. During the same period in the prior year, the company earned $1.83 EPS. The firm’s revenue was up 4.6% compared to the same quarter last year. Sell-side analysts forecast that Centene Co. will post 6.44 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts recently issued reports on CNC shares. Credit Suisse Group dropped their target price on shares of Centene from $94.00 to $87.00 in a research report on Wednesday, April 26th. The Goldman Sachs Group cut their price objective on shares of Centene from $97.00 to $74.00 and set a “neutral” rating for the company in a research report on Wednesday, February 8th. Mizuho lowered their price target on Centene from $92.00 to $80.00 and set a “neutral” rating on the stock in a research note on Tuesday, February 28th. Stephens reduced their price objective on Centene from $95.00 to $87.00 in a research report on Wednesday, April 26th. Finally, Deutsche Bank Aktiengesellschaft cut Centene from a “buy” rating to a “hold” rating and lowered their price objective for the company from $94.00 to $79.00 in a research report on Wednesday, March 8th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, Centene presently has a consensus rating of “Moderate Buy” and an average target price of $92.00.

About Centene

(Get Rating)

Centene Corp. operates as a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The company was founded in 1984 and is headquartered in St. Louis, MO.